Analysis of etiology and antibiotic susceptibility in acute exacerbation of bronchiectasis
10.3760/cma.j.issn.1673-4904.2019.02.018
- VernacularTitle:支气管扩张急性加重期病原学分布及耐药性特征分析
- Author:
Mianmian WU
1
;
Xuejian LIU
;
Mingyu LIAO
;
Li ZHAO
;
Guangyu JIAO
Author Information
1. 中国医科大学附属盛京医院第一呼吸内科
- Keywords:
Exacerbated bronchiectasis;
Etiology;
Drug sensitivity test
- From:
Chinese Journal of Postgraduates of Medicine
2019;42(2):164-168
- CountryChina
- Language:Chinese
-
Abstract:
Objective To Analyze the etiology and antibiotic susceptibility in exacerbated bronchiectasis, and guide rational drug use in clinic. Methods Pathogenic microorganism culture and drug sensitivity of sputum samples of 496 cases were collected from 2015 to 2016 in Shengjing Affiliated Hospital, China Medical University. The Excel software was used to analyze the screening data and the SPSS 22.0 was used for statistical analysis to obtain the drug resistance of the bacteria to the commonly used antibiotics. Results In 469 patients, there were 551 pieces of sputum , with 198 strains positive bacterium. Positive rate was 35.93％(198/551), and bacterium was 171 strains (86.36％). Bacteria of top three positive rate was 86 strains of Pseudomonas aeruginosa (50.29％), 54 strains of Acinetobacter baumannii (31.58％) and 10 strains of Klebsiella pneumoniae (5.85％). The resistance rate of Acinetobacter baumannii and Pseudomonas aeruginosa was higher, and other pathogens also showed various degrees of tolerance to antibiotic. Conclusions The pathogens in patients with acute exacerbation of bronchiectasis are Gram-negative bacteria. Considering the characters of Pseudomonas aeruginosa, it is not suggested to use cephalosporin of the third and fourth generation in treating Pseudomonas aeruginosa. Clinical selection of antibiotics should combine with the disease characteristics of patients in our hospital.
